Cardiorenal risk of celecoxib compared to naproxen, or ibuprofen in arthritis patients: a sub-analysis of the PRECISION trial
28 August 2018 (08:30 - 12:30)
Organised by:
Abstract
Slides
About the speaker
Royal Brompton and Harefield NHS Foundation Trust, London (United Kingdom of Great Britain & Northern Ireland)
11 More presentations in this session
Access the full session
The Event
ESC Congress 2018
28 August 2018
08:30 CET
